Barry Alan Firstenberg, DO Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1631 Lancaster Dr Ste 150, Grapevine, TX 76051 Phone: 817-251-9080 Fax: 817-251-9082 |
Dr. Heidi Ann Jordan, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1631 Lancaster, Suite 150, Grapevine, TX 76051 Phone: 817-251-9080 Fax: 817-251-9082 |
News Archive
Many surgical patients don't know that it's advisable to stop taking complementary and alternative medicine at least one to three weeks prior to surgery. During Patient Safety Awareness Week, March 13-19, 2016, the American Association of Nurse Anesthetists is reminding patients to bring a list of all medications - prescription or not - to their pre-anesthesia interview, and to share details about their medication use with their Certified Registered Nurse Anesthetist or other anesthesia professional.
MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new MEGA 7.5Fr. 30cc and 40cc intra-aortic balloon (IAB) catheters. These new, larger volume catheters will allow clinicians to provide patients with greater hemodynamic support, regardless of their height.
Australia could save AUD $3.4 billion in healthcare costs over the remaining lifetimes of all Australians alive in 2010 by instituting a combination of taxes on unhealthy foods and subsidies on fruits and vegetables, according to a new study published in PLOS Medicine by Linda Cobiac, from the University of Melbourne, Australia and colleagues.
Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, has moved its global corporate headquarters from Waltham, MA to Burlington, MA. The significantly larger office space located at 8 New England Executive Park in Burlington, MA allows the Company to plan for future growth.
A recent study reported in the May issue of the Journal of Nuclear Medicine demonstrates that Ga-68 DOTATATE PET/CT scans are superior to In-111 pentetreotide scans, the current imaging standard in the United States for detecting neuroendocrine tumors, and could significantly impact treatment management.
› Verified 1 days ago